ArticleBMC pediatrics2024

Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.

Rachel P Ogilvie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.